A61K 35/26
Lymph
Official title: Lymph; Lymph nodes; Thymus; Spleen; Splenocytes; Thymocytes
A61K35/26 (Lymph) appears on 145 US grants and 201 published applications in this corpus.
Search patents in A61K- Granted patents
- 145
- Published applications
- 201
- Assignees
- 142
- Inventors
- 408
- Latest grant
- 9 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1979 | 1 | 0 |
| 1980 | 1 | 0 |
| 1981 | 1 | 0 |
| 1982 | 0 | 0 |
| 1983 | 5 | 0 |
| 1984 | 1 | 0 |
| 1985 | 3 | 0 |
| 1986 | 2 | 0 |
| 1987 | 1 | 0 |
| 1988 | 2 | 0 |
| 1989 | 3 | 0 |
| 1990 | 1 | 0 |
| 1991 | 3 | 0 |
| 1992 | 1 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 6 | 0 |
| 1998 | 4 | 0 |
| 1999 | 2 | 0 |
| 2000 | 2 | 0 |
| 2001 | 3 | 1 |
| 2002 | 2 | 4 |
| 2003 | 2 | 4 |
| 2004 | 1 | 5 |
| 2005 | 1 | 5 |
| 2006 | 0 | 2 |
| 2007 | 0 | 4 |
| 2008 | 1 | 5 |
| 2009 | 2 | 11 |
| 2010 | 4 | 11 |
| 2011 | 5 | 6 |
| 2012 | 5 | 7 |
| 2013 | 3 | 6 |
| 2014 | 9 | 12 |
| 2015 | 8 | 8 |
| 2016 | 4 | 7 |
| 2017 | 5 | 9 |
| 2018 | 3 | 12 |
| 2019 | 6 | 11 |
| 2020 | 1 | 9 |
| 2021 | 13 | 7 |
| 2022 | 7 | 20 |
| 2023 | 2 | 7 |
| 2024 | 7 | 10 |
| 2025 | 6 | 9 |
| 2026 | 5 | 9 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Use of bovine spleen peptide powder in improving sleep, preventing or treating depression, or improving intestinal function9 Jun 2026US 12,648,965 B2Beijing No.1 Bio-Technology Development Co., Ltd.
- Methods and compositions for treating cancer24 Mar 2026US 12,582,626 B2The Wister Institute of Anatomy and Biology
- Altering gene expression in modified T cells and uses thereof17 Mar 2026US 12,577,567 B2The Trustees of the University of Pennsylvania
- Method for treating osteoarthritis with mesenchymal stem cell exosomes10 Mar 2026US 12,569,517 B2Direct Biologics, LLC
- Altering gene expression in modified T cells and uses thereof10 Mar 2026US 12,570,982 B2The Trustees of the University of Pennsylvania
- Methods for generating artificial thymus, products and uses thereof17 Sep 2026US 2026/0275290 A1
- Thymic cell compositions and methods of making3 Sep 2026US 2026/0256842 A1Thymmune Therapeutics, Inc.
- Injectable thymus organoids25 Jun 2026US 2026/0176586 A1Fibrobiologics, Inc.
- Bioengineering teritiary lymphoid structures using chitosan-based hydrogels7 May 2026US 2026/0124276 A1H. Lee Moffitt Cancer Center and Research Institute, Inc.
- Composition for cancer immunotherapy comprising secondary lymphoid organ-derived extracellular vesicle as active ingredient16 Apr 2026US 2026/0102432 A1Korea Institute of Science and Technology
Most cited
By later US patents
- Adoptive cell therapy with young T cells191US 8,383,099 B2The United States of America, as represented by the Secretary, Department of Health and Human Services · 2013
- Adoptive cell therapy with young T cells137US 9,074,185 B2The United States of America, as represented by the Secretary, Department of Health and Human Services · 2015
- T cell modifying compounds and uses thereof108US 9,597,357 B2Sangamo BioSciences, Inc. · 2017
- Simultaneous assay for T and B lymphocyte populations and subpopulations102US 4,511,662 ABio-Rad Laboratories, Inc. · 1985
- Method of metabolic adjuvanation and cellular repair70US 5,895,652 ALongevity Institute International · 1999